Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.49 USD | +0.29% | +19.93% | -17.10% |
05-02 | CUREVAC : A missed opportunity | |
04-26 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
9,707 PTS | +2.22% | +1.86% | - | ||
390 PTS | +0.99% | +4.86% | - | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.10% | 782M | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- CureVac N.V. Announces Results of the Second Interim Analysis of its International Pivotal Phase 2b/3 Study in Approximatively 40,000 Subjects